Cytek Biosciences' Cytek Aurora Evo system was named Drug Discovery Innovation of the Year in the 2026 BioTech Breakthrough Awards for its advanced spectral flow cytometry technology. The system offers higher throughput, automation, and reproducible data, helping pharmaceutical and research labs scale complex workflows efficiently. It reduces acquisition time by 40%, supports automated operation, and harmonizes instrument performance across locations. This recognition highlights Cytek's commitment to advancing drug discovery tools for more efficient and reliable research.
The Cytek Aurora Evo system's award for Drug Discovery Innovation of the Year is notable context for readers. For those following the health sector, 16 of 150 US stocks rose while 134 fell as of Nov 06, 2026 04:11 WIB. Among movers, XRAY dropped 17.18% to USD 8.82, TXG fell 15.60% to USD 56.99 with 88% sell orders, and TWST declined 15.28% to USD 120.79 with 96% sell orders.
Strawberry Fields REIT announced a cash dividend of $0.17 per common share for the fourth quarter of 2026. The dividend will be paid on December 30, 2026, to shareholders recorded by December 16, 2026. The company specializes in owning and leasing he...
Globe Life Inc. announced a quarterly dividend of $0.33 per share for shareholders of record as of January 8, 2027. This dividend will be paid on February 1, 2027. Globe Life is a holding company focused on life and supplemental health insurance for ...
Volatus Aerospace Inc., a global aerospace and defence company, will announce its financial results for the third quarter and nine months ended September 30, 2026, on November 10, 2026, after market close. The company will host a webinar featuring it...
Quantum BioPharma filed a supplement to its management circular correcting the treatment of fractional shares in its proposed share consolidation. Fractions of shares will be rounded up or down based on size. The company also clarified that voting po...
NFI Group Inc. announced its Q3 2026 financial results showing a 14.5% increase in revenue to $1.007 billion and a significant rise in gross profit by 231.1%, driven by better manufacturing and aftermarket margins. Net earnings improved dramatically ...
